Role of circulating miRNAs as biomarkers in idiopathic pulmonary arterial hypertension: Possible relevance of miR-23a

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Sarrion, Irene ^a   Milian, Lara ^b,c   Juan, G ^b,d   Ramon, Mercedes ^b,d   Furest, Idelfonso ^e   Carda, Carmen ^b,f   Cortijo Gimeno, Julio ^b,d,g   Mata Roig, Manuel ^b,f,g  

^a UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunitat Valenciana   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^e HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; BLOOD PRESSURE; DISEASES; GENE EXPRESSION; GENES; NUCLEIC ACIDS;

DISEASE PROGRESSION; EXPRESSION PROFILE; MIRNA EXPRESSIONS; NON-CODING RNAS; PULMONARY ARTERIAL HYPERTENSION; PULMONARY FUNCTION; PULMONARY HYPERTENSION; VASCULAR PATHOLOGY;

RNA;

BIOLOGICAL MARKER; CYTOCHROME C; GLUTATHIONE PEROXIDASE; HEME OXYGENASE 1; INTERLEUKIN 6; MESSENGER RNA; MICRORNA; MICRORNA 23A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; NFE2L2 PROTEIN, HUMAN; PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTERY ENDOTHELIUM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; LUNG FUNCTION; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PULMONARY ARTERY; PULMONARY HYPERTENSION; CELL CULTURE; GENETICS; METABOLISM; PATHOLOGY;

ANIMALIA;

ADULT; AGED; BIOMARKERS; CELLS, CULTURED; CYTOCHROMES C; FAMILIAL PRIMARY PULMONARY HYPERTENSION; FEMALE; GENE EXPRESSION PROFILING; HEME OXYGENASE-1; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NF-E2-RELATED FACTOR 2; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS;

EID: 84924599427     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/792846     Document Type: Article

References (74)

1. S. Rich, D. R. Dantzker, S. M. Ayres et al., "Primary pulmonary hypertension. A national prospective study," Annals of Internal Medicine, vol. 107, no. 2, pp. 216-223, 1987.
2. V. V. McLaughlin, S. L. Archer, D. B. Badesch et al., 'ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, and the Pulmonary Hypertension Association," Circulation, vol. 119, no. 16, pp. 2250-2294, 2009.
3. N. Galiè, M. M. Hoeper, M. Humbert et al., "ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)," European Heart Journal, vol. 30, no. 20, pp. 2493-2537, 2009.
4. M. Sano, T. Minamino, H. Toko et al., "p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload," Nature, vol. 446, no. 7134, pp. 444-448, 2007.
5. N. F. Voelkel, R. A. Quaife, L. A. Leinwand et al, "Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure," Circulation, vol. 114, no. 17, pp. 1883-1891, 2006.
6. M. Mata, I. Sarrion, L. Milian et al., "PGC-1 α induction in pulmonary arterial hypertension," Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 236572, 8 pages, 2012.
7. Z. Wu, R Puigserver, U. Andersson et al., "Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1," Cell, vol. 98, no. 1, pp. 115-124, 1999.
8. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function," Cell, vol. 116, no. 2, pp. 281-297, 2004.
9. D. S. Schwarz, G. Hutvágner, T. Du, Z. Xu, N. Aronin, and P. D. Zamore, "Asymmetry in the assembly of the RNAi enzyme complex," Cell, vol. 115, no. 2, pp. 199-208, 2003.
10. V. Di Stefano, G Zaccagnini, M. C. Capogrossi, and E Martelli, "microRNAs as peripheral blood biomarkers of cardiovascular disease," Vascular Pharmacology, vol. 55, no. 4, pp. 111-118, 2011.
11. G.-K. Wang, J.-Q. Zhu, J.-T. Zhang et al, "Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans," European Heart journal, vol. 31, no. 6, pp. 659-666, 2010.
12. O. Gidlöf, P. Andersson, J. van der Pals, M. Götberg, and D. Erlinge, "Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples," Cardiology, vol. 118, no. 4, pp. 217-226, 2011.
13. X. Ji, R. Takahashi, Y. Hiura, G. Hirokawa, Y. Fukushima, and N. Iwai, "Plasma miR-208 as a biomarker of myocardial injury," Clinical Chemistry, vol. 55, no. 11, pp. 1944-1949, 2009.
14. A. Lee, D. McLean, J. Choi, H. Kang, W. Chang, and J. Kim, "Therapeutic implications of micro RNAs in pulmonary arterial hypertension," BMB Reports, vol. 47, no. 6, pp. 311-317, 2014.
15. W. Y Li, J. Jin, J. Chen, Y Guo, J. Tang, and S. Tan, "Circulating micro RNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke," Journal of Human Hypertension, vol. 28, no. 5, pp. 288-291, 2014.
16. C. Li and W. H. Wong, "Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 1, pp. 31-36, 2001.
17. 2 via mechanisms involving AP-1 activation," Free Radical Research, vol. 46, no. 5, pp. 690-699, 2012.
18. J. L. Ortiz, J. Milara, G. Juan et al., "Direct effect of cigarette smoke on human pulmonary artery tension," Pulmonary Pharmacology and Therapeutics, vol. 23, no. 3, pp. 222-228, 2010.
19. M. Mata, B. Sarriá, A. Buenestado, J. Cortijo, M. Cerdá, and E. J. Morcillo, "Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells," Thorax, vol. 60, no. 2, pp. 144-152, 2005.
20. R. Qi, M. Weiland, X H. Gao, L. Zhou, and Q.-S. Mi, "Identification of endogenous normalizers for serum MicroRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer," Hepatology, vol. 55, no. 5, pp. 1640-1642, 2012.
21. A. Courboulin, R. Paulin, N. J. Giguère et al., "Role for miR-204 in human pulmonary arterial hypertension," Journal of Experimental Medicine, vol. 208, no. 3, pp. 535-548, 2011.
22. C. L. Bockmeyer, L. Maegel, S. Janciauskiene et al., "Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression," Journal of Heart and Lung Transplantation, vol. 31, no. 7, pp. 764-772, 2012.
23. C. Lee, S. A. Mitsialis, M. Aslam et al., "Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension," Circulation, vol. 126, no. 22, pp. 2601-2611, 2012.
24. C. Wei, H. Henderson, C. Spradley et al., "Circulating miRNAs as potential marker for pulmonary hypertension," PLoS ONE, vol. 8, no. 5, Article ID e64396, 2013.
25. P. Caruso, Y Dempsie, H. C. Stevens et al., "A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples," Circulation Research, vol. 111, no. 3, pp. 290-300, 2012.
26. K. M. Drake, D. Zygmunt, L. Mavrakis et al., "Altered microRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8," The American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 12, pp. 1400-1408, 2011.
27. L. Guo, Z. Qiu, L. Wei et al, "The MicroRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 Receptor and L-type calcium channel-α1C," Hypertension, vol. 59, no. 5, pp. 1006-1013, 2012.
28. Y Mishima, C. Stahlhut, and A. J. Giraldez, "miR-1-2 gets to the heart of the matter," Cell, vol. 129, no. 2, pp. 247-249, 2007
29. K. R. Cordes, D. Srivastava, and K. N. Ivey, "MicroRNAs in cardiac development," Pediatric Cardiology, vol. 31, no. 3, pp. 349-356, 2010.
30. A. Safdar, A. Abadi, M. Akhtar, B. P. Hettinga, and M. A. Tarnopolsky, "miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57B1/6J male mice," PLoS ONE, vol. 4, no. 5, Article ID e5610, 2009.
31. S. Medrano, M. C. Monteagudo, M. L. S. Sequeira-Lopez, E. S. Pentz, and R. Ariel Gomez, "Two microRNAs, miR-330 and miR-125b-5p, mark the juxtaglomerular cell and balance its smooth muscle phenotype," The American Journal of Physiology-Renal Physiology, vol. 302, no. 1, pp. 29-37, 2012.
32. S. Rane, M. He, D. Sayed et al., "Downregulation of MiR-199a derepresses hypoxia-inducible factor-lα and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes," Circulation Research, vol. 104, no. 7, pp. 879-886, 2009.
33. V. Huang, R. E Place, V. Portnoy et al., "Upregulation of cyclin B1 by miRNA and its implications in cancer," Nucleic Acids Research, vol. 40, no. 4, pp. 1695-1707, 2012.
34. E. van Rooij, L. B. Sutherland, N. Liu et al., "A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 48, pp. 18255-18260, 2006.
35. B. Wang, S.-H. Hsu, W. Frankel, K. Ghoshal, and S. T. Jacob, "Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating Glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha," Hepatology, vol. 56, no. 1, pp. 186-197, 2012.
36. B. Wang, S. H. Hsu, W. Frankel, K. Ghoshal, and S. T. Jacob, "Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating Glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha," Hepatology, vol. 56, no. 1, pp. 186-197, 2012.
37. G. Kim, M. Ouzounova, A. A. Quraishi et al., "SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model," Oncogene, vol. 34, pp. 671-680, 2015.
38. S. Rich, D. R. Dantzker, S. M. Ayres et al., "Primary pulmonary hypertension. A national prospective study," Annals of Internal Medicine, vol. 107, no. 2, pp. 216-223, 1987.
39. V. V. McLaughlin, S. L. Archer, D. B. Badesch et al., 'ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, and the Pulmonary Hypertension Association," Circulation, vol. 119, no. 16, pp. 2250-2294, 2009.
40. N. Galiè, M. M. Hoeper, M. Humbert et al., "ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)," European Heart Journal, vol. 30, no. 20, pp. 2493-2537, 2009.
41. M. Sano, T. Minamino, H. Toko et al., "p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload," Nature, vol. 446, no. 7134, pp. 444-448, 2007.
42. N. F. Voelkel, R. A. Quaife, L. A. Leinwand et al, "Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure," Circulation, vol. 114, no. 17, pp. 1883-1891, 2006.
43. M. Mata, I. Sarrion, L. Milian et al., "PGC-1 α induction in pulmonary arterial hypertension," Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 236572, 8 pages, 2012.
44. Z. Wu, R Puigserver, U. Andersson et al., "Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1," Cell, vol. 98, no. 1, pp. 115-124, 1999.
45. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function," Cell, vol. 116, no. 2, pp. 281-297, 2004.
46. D. S. Schwarz, G. Hutvágner, T. Du, Z. Xu, N. Aronin, and P. D. Zamore, "Asymmetry in the assembly of the RNAi enzyme complex," Cell, vol. 115, no. 2, pp. 199-208, 2003.
47. V. Di Stefano, G Zaccagnini, M. C. Capogrossi, and E Martelli, "microRNAs as peripheral blood biomarkers of cardiovascular disease," Vascular Pharmacology, vol. 55, no. 4, pp. 111-118, 2011.
48. G.-K. Wang, J.-Q. Zhu, J.-T. Zhang et al, "Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans," European Heart journal, vol. 31, no. 6, pp. 659-666, 2010.
49. O. Gidlöf, P. Andersson, J. van der Pals, M. Götberg, and D. Erlinge, "Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples," Cardiology, vol. 118, no. 4, pp. 217-226, 2011.
50. X. Ji, R. Takahashi, Y. Hiura, G. Hirokawa, Y. Fukushima, and N. Iwai, "Plasma miR-208 as a biomarker of myocardial injury," Clinical Chemistry, vol. 55, no. 11, pp. 1944-1949, 2009.
51. A. Lee, D. McLean, J. Choi, H. Kang, W. Chang, and J. Kim, "Therapeutic implications of micro RNAs in pulmonary arterial hypertension," BMB Reports, vol. 47, no. 6, pp. 311-317, 2014.
52. W. Y Li, J. Jin, J. Chen, Y Guo, J. Tang, and S. Tan, "Circulating micro RNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke," Journal of Human Hypertension, vol. 28, no. 5, pp. 288-291, 2014.
53. C. Li and W. H. Wong, "Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 1, pp. 31-36, 2001.
54. 2 via mechanisms involving AP-1 activation," Free Radical Research, vol. 46, no. 5, pp. 690-699, 2012.
55. J. L. Ortiz, J. Milara, G. Juan et al., "Direct effect of cigarette smoke on human pulmonary artery tension," Pulmonary Pharmacology and Therapeutics, vol. 23, no. 3, pp. 222-228, 2010.
56. M. Mata, B. Sarriá, A. Buenestado, J. Cortijo, M. Cerdá, and E. J. Morcillo, "Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells," Thorax, vol. 60, no. 2, pp. 144-152, 2005.
57. R. Qi, M. Weiland, X H. Gao, L. Zhou, and Q.-S. Mi, "Identification of endogenous normalizers for serum MicroRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer," Hepatology, vol. 55, no. 5, pp. 1640-1642, 2012.
58. A. Courboulin, R. Paulin, N. J. Giguère et al., "Role for miR-204 in human pulmonary arterial hypertension," Journal of Experimental Medicine, vol. 208, no. 3, pp. 535-548, 2011.
59. C. L. Bockmeyer, L. Maegel, S. Janciauskiene et al., "Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression," Journal of Heart and Lung Transplantation, vol. 31, no. 7, pp. 764-772, 2012.
60. C. Lee, S. A. Mitsialis, M. Aslam et al., "Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension," Circulation, vol. 126, no. 22, pp. 2601-2611, 2012.
61. C. Wei, H. Henderson, C. Spradley et al., "Circulating miRNAs as potential marker for pulmonary hypertension," PLoS ONE, vol. 8, no. 5, Article ID e64396, 2013.
62. P. Caruso, Y Dempsie, H. C. Stevens et al., "A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples," Circulation Research, vol. 111, no. 3, pp. 290-300, 2012.
63. K. M. Drake, D. Zygmunt, L. Mavrakis et al., "Altered microRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8," The American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 12, pp. 1400-1408, 2011.
64. L. Guo, Z. Qiu, L. Wei et al, "The MicroRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 Receptor and L-type calcium channel-α1C," Hypertension, vol. 59, no. 5, pp. 1006-1013, 2012.
65. Y Mishima, C. Stahlhut, and A. J. Giraldez, "miR-1-2 gets to the heart of the matter," Cell, vol. 129, no. 2, pp. 247-249, 2007
66. K. R. Cordes, D. Srivastava, and K. N. Ivey, "MicroRNAs in cardiac development," Pediatric Cardiology, vol. 31, no. 3, pp. 349-356, 2010.
67. A. Safdar, A. Abadi, M. Akhtar, B. P. Hettinga, and M. A. Tarnopolsky, "miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57B1/6J male mice," PLoS ONE, vol. 4, no. 5, Article ID e5610, 2009.
68. S. Medrano, M. C. Monteagudo, M. L. S. Sequeira-Lopez, E. S. Pentz, and R. Ariel Gomez, "Two microRNAs, miR-330 and miR-125b-5p, mark the juxtaglomerular cell and balance its smooth muscle phenotype," The American Journal of Physiology-Renal Physiology, vol. 302, no. 1, pp. 29-37, 2012.
69. S. Rane, M. He, D. Sayed et al., "Downregulation of MiR-199a derepresses hypoxia-inducible factor-lα and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes," Circulation Research, vol. 104, no. 7, pp. 879-886, 2009.
70. V. Huang, R. E Place, V. Portnoy et al., "Upregulation of cyclin B1 by miRNA and its implications in cancer," Nucleic Acids Research, vol. 40, no. 4, pp. 1695-1707, 2012.
71. E. van Rooij, L. B. Sutherland, N. Liu et al., "A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 48, pp. 18255-18260, 2006.
72. B. Wang, S.-H. Hsu, W. Frankel, K. Ghoshal, and S. T. Jacob, "Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating Glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha," Hepatology, vol. 56, no. 1, pp. 186-197, 2012.
73. B. Wang, S. H. Hsu, W. Frankel, K. Ghoshal, and S. T. Jacob, "Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating Glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha," Hepatology, vol. 56, no. 1, pp. 186-197, 2012.
74. G. Kim, M. Ouzounova, A. A. Quraishi et al., "SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model," Oncogene, vol. 34, pp. 671-680, 2015.